NMPA, Announcement on Imported Certificated Medical Devices product Transfer to Domestic Production in China

The NMPA publicly solicited opinions on the Announcement of Matters concerning the Transfer of Products with The Registration Certificate of Imported Medical Devices to Enterprises within the territory of China (Draft for Comments)

In order to implement the "regulation and service" reform and optimize the business environment, we will deepen the reform of the medical device evaluation and approval system, further simplify and optimize the requirements for medical device licensing, and meet the people's needs for use. The NMPA has organized the drafting of the Announcement on Matters Concerning the imported certificated medical devices products transfer to Chinese domestic enterprise production related matters (Draft for Comments), it is now open for public comments. Please send your comments or Suggestions by email to ylqxzc@sina.cn before March 31, 2020. Please indicate "feedback on matters related to product transfer and production" in the email subject.


Contact Us
CIRS China

Mr. Harold Xie (Head office)
Tel: +86-571 8720 6559 | Fax: +86-571 87206533
Email: md@cirs-group.com
Mr. Edwin Wen (Beijing office)
Tel: +86-10 63984062 | Fax: +86-10 63984032
Email: md@cirs-group.com

CIRS Europe

Bryan Zhou
Tel:  +353 (1)477 3710

Email: md@cirs-group.com

CIRS Korea
Mr. Junho Lee 
Tel: +82 2 6347 8801 
Email: md@cirs-group.com